Portfolio


3SBio

IPO in 2015 (HKSE: 1530)


Aadi

IPO in 2021 (NASDAQ: AADI)


Accuragen

 


ACELYRIN

IPO in 2023 (NASDAQ: SLRN)


Adaptive Biotechnologies

IPO in 2019 (NASDAQ: ADPT)


Adela

 


AK Medical

IPO in 2017 (HKSE: 1789)


Albireo Pharma

Acquired by Ipsen


Alpine Immune Sciences

Acquired by Vertex


AnHeart Therapeutics

Acquired by Nuvation Bio (NYSE: NUVB)


Arcus Biosciences

IPO in 2018 (NASDAQ: RCUS)


Ariagen

 


Ark Biosciences

 


ARMO Biosciences

Acquired by Eli Lilly


BCFoods

 


BeyondSpring Pharmaceuticals

NASDAQ: BYSI


Bioheng

 


Cellares

 


Cellular Research

Acquired by Becton Dickinson


Centricity Vision

 


CG Oncology

IPO in 2024 (NASDAQ: CGON)


Checkmate Pharmaceuticals

Acquired by Regeneron


Cirina

Acquired by GRAIL


ConjugateBio

 


Cue Health

IPO in 2021 (NASDAQ: HLTH)


Dragon Crown

 


Encodia

 


EpimAb Biotherapeutics

 


Equillium Bio

NASDAQ: EQ


Everest Medicines

IPO in 2020 (HKSE: 1952)


Firefly Biologics

 


GeneWEAVE

Acquired by Roche


GRAIL

Acquired by Illumina


GRIT Biotechnology

 


GYT Healthcare Services

 


Harton Therapeutics

 


Hummingbird Bioscience

 


ImmPACT Bio

 


IMPACT Therapeutics

 


Insight Lifetech

 


Invitae

IPO in 2016 (NASDAQ: NVTA)


KeChow Pharma

 


Shanghai Legend Medical

 


LevitasBio

 


LYNK Pharmaceuticals

 


Mammoth Biosciences

 


MDCO

 


Medical Creations

 


Mirvie

 


Nalu Medical

 


Omniome

Acquired by Pacific Biosciences


PackGene Biotech

 


PerMedos

 


Phrontline

 


Polares Medical

 


Prometheus Biosciences

Acquired by Merck


ReadCoor

Acquired by 10X Genomics


Scynexis

NASDAQ: SCYX


SentreHEART

Acquired by Atricure


Shape Therapeutics

 


SINO Medical Sciences Technology

IPO in 2019 (SHA: 688108)


Solve Therapeutics

 


Take2

 


Terns Pharmaceutical

IPO in 2021 (NASDAQ: TERN)


Upstream Bio

 


USCI Medical Laboratory

 


VelosBio

Acquired by Merck


VintaBio

 


Watchmaker Genomics

 


YolTech Therapeutics

 


Zentalis

NASDAQ: ZNTL